Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Suzhou Zelgen Biopharmaceuticals Co.,Ltd)"
Count: 47
Selected: 0
| NCT ID | Title |
|---|
| NCT04612712 | A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors | ||
| NCT02645981 | Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT02229071 | Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT05584800 | A Safety and Tolerability Study ZGGS18 | ||
| NCT05526222 | A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis | ||
| NCT05279001 | A Safety and Tolerability Study of Jaktinib | ||
| NCT05255237 | Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata | ||
| NCT05150717 | ADME Study of [14C]-Jaktinib in Healthy Male Subjects | ||
| NCT05051761 | Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata | ||
| NCT04993404 | Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function | ||
| NCT04971551 | A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease. | ||
| NCT04971473 | Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal | ||
| NCT04964284 | Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer | ||
| NCT04866056 | Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF. | ||
| NCT04851535 | Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refratory of Ruxolitinib Treatment. | ||
| NCT04816123 | The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man | ||
| NCT04617028 | Jaktinib Versus Hydroxycarbamide in Subjects With Intermediate-2 or High-risk Myelofibrosis | ||
| NCT04612699 | A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis | ||
| NCT04605185 | Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma | ||
| NCT04539639 | Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis | ||
| NCT04507659 | Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis | ||
| NCT04503902 | Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma | ||
| NCT04472858 | A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors | ||
| NCT04459871 | Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis | ||
| NCT04447183 | The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer. | ||
| NCT04445363 | A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata | ||
| NCT04435392 | Jaktinib Hydrochloride Cream For Atopic Dermatitis | ||
| NCT04402723 | Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML | ||
| NCT04312594 | Jaktinib Dihydrochloride Monohydrate in Idiopathic Pulmonary Fibrosis | ||
| NCT04217993 | Jaktinib Hydrochloride for the Treatment of Ruxolitinib Intolerance of Myelofibrosis | ||
| NCT04211922 | Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib | ||
| NCT04137185 | Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients | ||
| NCT04034134 | Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata | ||
| NCT04032821 | To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects | ||
| NCT03886415 | Jaktinib Hydrochloride Tablets in Intermediate-risk and High-risk Myelofibrosis. | ||
| NCT03611426 | Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy | ||
| NCT03607188 | A Phase I Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer | ||
| NCT03602495 | A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer | ||
| NCT03314402 | The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers | ||
| NCT02870582 | Donafenib for Previously Treated Metastatic Colorectal Cancer | ||
| NCT02870569 | Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer | ||
| NCT02698111 | Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma | ||
| NCT02489916 | Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer | ||
| NCT02489214 | Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer | ||
| NCT02489201 | A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer | ||
| NCT05576909 | Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation | ||
| NCT05161143 | Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma |
